- Home
- IH vs CUE Comparison
IH vs CUE Comparison
Compare IH & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IH
- CUE
- Stock Information
- Founded
- IH 1996
- CUE 2014
- Country
- IH China
- CUE United States
- Employees
- IH N/A
- CUE N/A
- Industry
- IH Other Consumer Services
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- IH Real Estate
- CUE Health Care
- Exchange
- IH Nasdaq
- CUE Nasdaq
- Market Cap
- IH 88.8M
- CUE 77.3M
- IPO Year
- IH 2020
- CUE 2018
- Fundamental
- Price
- IH $1.67
- CUE $1.31
- Analyst Decision
- IH
- CUE Strong Buy
- Analyst Count
- IH 0
- CUE 5
- Target Price
- IH N/A
- CUE $5.00
- AVG Volume (30 Days)
- IH 12.2K
- CUE 406.9K
- Earning Date
- IH 02-27-2025
- CUE 03-10-2025
- Dividend Yield
- IH N/A
- CUE N/A
- EPS Growth
- IH N/A
- CUE N/A
- EPS
- IH 0.28
- CUE N/A
- Revenue
- IH $134,002,994.00
- CUE $9,532,000.00
- Revenue This Year
- IH $15.90
- CUE $73.11
- Revenue Next Year
- IH $8.64
- CUE $11.02
- P/E Ratio
- IH $6.00
- CUE N/A
- Revenue Growth
- IH N/A
- CUE 149.53
- 52 Week Low
- IH $1.47
- CUE $0.45
- 52 Week High
- IH $2.94
- CUE $2.93
- Technical
- Relative Strength Index (RSI)
- IH 48.69
- CUE 52.47
- Support Level
- IH $1.60
- CUE $1.21
- Resistance Level
- IH $1.74
- CUE $1.75
- Average True Range (ATR)
- IH 0.10
- CUE 0.18
- MACD
- IH 0.00
- CUE 0.00
- Stochastic Oscillator
- IH 52.17
- CUE 45.00
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.